Answers are grounded in this paper and cite their sources.
Algaze et al. [2013], reported on a newborn affected by Adams–Oliver syndrome (AOS) with truncus arteriosus (TA) and reviewed cardiovascular malformations (CVMs) in published AOS subjects, suggesting that the association with TA was unprecedented. AOS is a rare genetic disorder characterized by aplasia cutis congenita and terminal transverse limb defects. CVMs occur in 13–20% of these patients, and different anatomic types have been reported including left-sided obstructive lesions, septal and conotruncal defects, and tricuspid atresia [Lin et al., 1993, 1998; Zapata et al., 1995; Swartz et al., 1999; Sankhyan et al., 2006]. Left-sided obstructive lesions are prevailing, particularly multiple levels anomalies characteristic of Shone complex (parachute mitral valve, hypoplastic left ventricle, bicuspid aortic valve, and hypoplastic aortic arch) [Zapata et al., 1995; Lin et al., 1998]. AOS is characterized by high intra- and inter-familial variability. We have previously reviewed the CVMs associated with partial forms of AOS, speculating that the association between CVMs and aplasia cutis congenita, even without limb defects, could be etiologically related to AOS [Digilio et al., 2008]. On one hand, literature review shows intra-familial variability, including co-segregation of classic and partial AOS in a few families [Santos et al., 1989; Lin et al., 1998]. Notably, some members displayed full blown features of AOS, while others had CVMs and aplasia cutis without limb defects [Bruel et al., 1999; Heras Mulero et al., 2007; Digilio et al., 2008]. On the other hand, concordant partial AOS can also segregate in the same family, as illustrated by a mother–son pair sharing aplasia cutis congenital and aortic coarctation with normal limbs [Dallapiccola et al., 1992; Digilio et al., 2008]. Inherited susceptibility to generalized vasculopathy resulting in disruption of fetal blood flow could account for most of the AOS clinical features, including left-sided obstructive lesions [Hoyme et al., 1991; Piazza et al., 2004]. We agree with Algaze et al. [2013] that a different pathogenic mechanism could be responsible for AOS and conotruncal defects. Anomalies in neural crest cell migration have been implicated in both craniofacial [Minoux and Rifli, 2010] and conotruncal cardiac development [Van Mierop and Kutsche, 1986; Kirby and Waldo, 1995; Poelmann et al., 1998]. Neural crest cell migration anomalies have been involved in deletion 22q11.2 (del22q) syndrome (DiGeorge/velo-cardio-facial syndrome). Within the personal series of about 330 children with del22q, we found one female with classic 3 Mb deletion presenting with aplasia cutis congenita affecting the scalp vertex. Remarkably, vascular insufficiency or disruptions have been suspected to cause some features of the del22q [Shprintzen, 2005]. Several AOS families display the recurrence of CVM. In particular, in individual pedigrees cardiac defects are found which result from the same pathogenic pathway [Zapata et al., 1995; Lin et al., 1998]. In known families with AOS and conotruncal heart defect, no relatives with left-sided obstructions were recorded (Table I). Concordant segregation of AOS and tetralogy of Fallot (ToF) was described in a father–sib pair, although the father expressed cardiac defect and terminal transverse limb defects only [Der Kaloustian et al., 1991]. These observations argue that different genes could be causally involved in sporadic and familial AOS associated with different types of cardiac defects. In fact, AOS is an heterogeneous disorder with mutations in different genes and different patterns of inheritance, including ARHGAP31 gene [Southgate et al., 2011], DOCK6 gene [Shaheen et al., 2011, 2013], RBPJ gene [Hassed et al., 2012], and EOGT gene [Shaheen et al., 2013]. Cardiac defects, in particular septal defects, have been found only in the 9% of patients with mutations in any of the known genes [Table II]. Apparently, genes causing AOS and left-sided obstructive lesions or conotruncal defects have not been identified yet. RBPJ gene could be candidate for AOS with left-sided obstructive lesions, since it codes for an evolutionarily conserved protein coordinating the transcriptional activation of Notch-target genes through the assembly of protein complexes containing co-activators. RBPJ-mediated NOTCH signaling is important for mesenchymal cell proliferation, skeletal and vascular formation, epidermis and hair-follicle development [Dou et al., 2008]. RBPJ conditional-knockout mice have arteriovenous malformations [Krebs et al., 2004]. We have previously hypothesized a link between Notch and AOS, based on the association between cardiovascular malformations and aplasia cutis congenita [Digilio et al., 2008]. In fact, the Notch signaling pathway was implicated in cardiac valve development, and heterozygous NOTCH1 mutations in humans disrupt normal development of the aortic valve and occasionally the mitral valve [Garg et al., 2005]. The severity of aortic valve disease associated with NOTCH1 mutations in humans varies from mild bicuspid aortic valve to hypoplastic left heart syndrome, arguing that disruption of the NOTCH signaling cascade may underlie a spectrum of left-sided obstructive CHDs. Nevertheless, all patients with AOS and RPBJ gene mutations have a normal heart [Hassed et al., 2012]. In conclusion, clinical evidence substantiates the idea that AOS is a heterogeneous disorder, arguing that different clinical presentations could be due to distinct embryological mechanisms. Further molecular studies are needed to elucidate the genetic background of cardiac manifestations in AOS. Clinical heterogeneity within AOS and the presence of partial manifestations must also be considered. In particular, it is likely that its association with conotruncal defect could be less rare than currently estimated, since patients with partial forms may be overlooked.
No takes yet. Share an insight, caveat, or question.
Digilio et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: